Obesity Cohort Bichat Louis Mourier
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · May 15, 2018
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Obesity Cohort Bichat Louis Mourier, aims to better understand severe obesity and the effects of bariatric surgery, which is a type of surgery designed to help people lose weight. The researchers believe that by studying biological samples—like blood and tissue—taken from patients undergoing different types of weight loss surgery, they can learn more about how obesity affects the body, particularly the gastrointestinal tract. This could lead to improved treatments for obesity and potentially identify alternatives to surgery.
To participate in this study, individuals must be severely obese, with a body mass index (BMI) over 35, and at least 18 years old. They should also be candidates for specific types of bariatric surgery, such as sleeve gastrectomy or gastric bypass, or need a follow-up surgery due to complications or insufficient weight loss from a previous surgery. Participants can expect to provide biological samples during their surgery, and these samples will help researchers explore how weight loss and surgery impact the body. It's important to note that individuals with certain health conditions, such as severe psychiatric disorders or organ failure, will not be eligible to participate.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • severe obese subject with BMI above35 kg/m2, age above 18 ans who accept to participate
- • candidate for bariatric surgery according to HAS criteria
- • who will undergo either sleeve gastrectomy or gastric bypass
- • or who undergoesa revisional surgery for a complication of bariatric surgery
- • or who undergoes arevisional sugery fir insufficient weight loss
- • covered by an health insurance
- Exclusion Criteria:
- • psychiatric disease or undertanding disorder
- • alchool abuse or other addiction
- • organ failure (including liver, heart or kidney)
- • chronic life-threatening illness
- • inflamatory disease or immunosuppressive treatment
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Colombes, Ile De France, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials